“8‐pCPT‐2′‐O‐Me‐cAMP, an Epac‐selective cAMP analogue, and glibenclamide, a sulfonylurea, synergistically activate Epac2A and Rap1, whereas adrenaline , which suppresses cAMP production in pancreatic β‐cells, blocks activation of Epac2A and Rap1 by glibenclamide.”